# Lenalidomide

NDC: 69097-604
Generic name: Lenalidomide
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20230309

FDA application: ANDA214618

## Active ingredients

- LENALIDOMIDE: 2.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-604"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-604
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96df285d-dd13-4083-b2c6-e5c799e7587b